logo
ASX to slip, Fed decision and Powell's comments awaited

ASX to slip, Fed decision and Powell's comments awaited

Australian shares are poised to rise, tracking gains in New York after data reconfirmed the resilience of the US economy. Investors are waiting for the Federal Reserve's 4am AEST policy decision.
Meta and Microsoft are set to report results after Wall Street's closing bell at 6am AEST.
US government bond yields were higher after the Treasury Department signalled it will rely more on the shortest-dated securities to fund the gaping federal deficit at least until 2026.
The S&P 500, coming off its best streak of gains since 2020, is about to enter what has historically been its toughest stretch of the year.
Over the past three decades, the benchmark has performed the worst in August and September, losing 0.7 per cent on average in each month, compared with a 1.1 per cent gain on average across other months, data compiled by Bloomberg show.
The US economy expanded an annualised 3 per cent pace in the June quarter, however economists were wary of reading too much into the print.
'We retain our outlook for a slowdown in US GDP growth in 2024, as restrictive trade and immigration policies outweigh the benefits from fiscal policy and deregulation,' Morgan Stanley's Michael Gapen wrote in a note.
'Prior to this report, we were forecasting Q4/Q4 growth of 0.8 per cent in 2025; we now expect 1.0 per cent, reflecting the stronger 2Q out turn but no extrapolation into later quarters. We continue to expect 1.1 per cent growth in 2026.'
Market highlights
ASX futures are pointing down 7 points or 0.1 per cent to 8708.
All US prices near 2.30pm New York time.
*Bloomberg pricing
Today's agenda
Quarterly reports expected on Thursday from Beach Energy, Liontown Resources and Origin Energy.
RBA deputy governor Andrew Hauser will participate in a fireside chat at the Barrenjoey Economic Forum, Sydney at 9.20am AEST.
A wave of data is set for release at 11.30am AEST, including June retail sales, building approvals, private sector as well as import and export price data. NAB said its retail transactions data suggests a strong rise in the month and 'we have pencilled in a 1.0 per cent month-over-month increase'.
As for overseas, Japan will release June retail sales and industrial output, China will release manufacturing and non-manufacturing PMIs for July and the Bank of Japan will hold a policy meeting. Later, the US will release June personal spending and core PCE price data, a quarterly employment cost index and weekly jobless claims.
On the BoJ decision, TD Securities said: ' US-Japan trade deal was struck, but we expect the BoJ to stand pat this month, holding the target rate at 0.5 per cent.
'After the poor showing of the ruling coalition in the Upper House elections, PM Ishiba is facing calls to step down and Japan is likely to enter a phase of political uncertainty. That said, Governor Ueda may signal a hike in October is still on the table as inflation is running at a 30-year high and we will get more clarity on both trade and politics then.'
Top stories
Rio Tinto boss defends lithium push as earnings slump cuts dividend | The country's biggest iron ore exporter will pay its lowest dividend since 2018 after lower prices and weaker sales volumes hurt its half-year bottom line.
| India 'is our friend', the US president said on his Truth Social platform, but its tariffs 'are far too high' on US products.
Atlassian gang back together as Farquhar hits Canberra to spruik AI | The billionaire co-founders of the software giant reunited at the National Press Club, setting aside long speculation of a rift in their relationship.
| A broader push for higher taxes at the productivity roundtable in August could soften hostility towards the proposed super tax, the government believes.
| Commonwealth Bank held the rights to sponsor Cricket Australia for four decades – then Westpac CEO Anthony Miller stole it from under their nose.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Sydney Morning Herald

time26 minutes ago

  • Sydney Morning Herald

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines
‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

The Age

time26 minutes ago

  • The Age

‘A very big threat': Australia defends PBS as Trump flags 250% tariffs on medicines

Health Minister Mark Butler is planning to speed up medicines approvals as United States President Donald Trump threatens to put tariffs of up to 250 per cent on pharmaceutical products, which could affect $2 billion worth of Australian exports. Butler said Trump's latest threat would not change the discount Australians received on medicines through the Pharmaceutical Benefits Scheme, but revealed he would get advice within days about accelerating the approvals process for new drugs in Australia – a key issue that US pharmaceutical giants have raised with Trump. Speeding up the timeframe for US medicines to land on pharmacy shelves could improve the Australian government's standing with the Trump administration, although it does not deal with the White House's bigger concern that Americans pay more for medicines than citizens of other countries. Trump's anger with what he called 'foreign freeloading nations' prompted him to threaten tariffs of up to 250 per cent on drug imports this week. Butler said it was a 'a very big threat'. 'It's one we're working very hard to engage with the Americans on,' Butler said on Thursday. Loading 'The numbers are jumping around … They were 200 per cent a couple of weeks ago, and now they're 250 per cent potentially. They are very, very big tariffs. 'We are making the case very strongly, but I'm not going to pretend that the US Administration doesn't appear to be pretty serious about this.' Australia's PBS – under which the government subsidises drugs and Australians can buy expensive medicines for a maximum price of $31.60, soon to become $25 – has been brought up repeatedly during Trump's trade wars as US pharmaceutical companies push the president to punish countries that limit their market access.

Redcape buys $30m Queensland pub, launches capital raise
Redcape buys $30m Queensland pub, launches capital raise

AU Financial Review

time26 minutes ago

  • AU Financial Review

Redcape buys $30m Queensland pub, launches capital raise

Redcape Hotel Group has bought The Orion Hotel in south-east Queensland for $30 million and launched a capital raising to fund more deals as it swings back strongly into expansion phase. It's the latest in a string of acquisitions by the hotel fund over the past 12 months, totalling around $250 million. The unlisted fund, one of the biggest of those managed by ASX-listed MA Financial, has accumulated a $1 billion portfolio of hotels in NSW and Queensland.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store